CD86 and neoplasm: Cytotoxic T lymphocyte associated protein 4 (CTLA4) is an immune-checkpoint molecule on T cells which interactes with CD80 (B7-1) and CD86 (B7-2) on tumor cells to inhibit the induction phase of the T cell response.